Results 151 to 160 of about 10,131,417 (246)
Research progress on intestinal tract management after anterior resection of rectal cancer
This article reviewed the evaluation tools for intestinal function and intervention plans for intestinal symptoms after anterior resection of rectal cancer,providing reference for subsequent intestinal management plans.
CAO Kaikai, SHI Xiaoyan
doaj
Structured pelvic floor physiotherapy rehabilitation for low anterior resection syndrome in colorectal cancer: An Australian feasibility study. [PDF]
Chan KYC +5 more
europepmc +1 more source
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia +4 more
wiley +1 more source
'Everyone has their own way-there's no protocol'. An Australian qualitative study of clinician perspectives on the management of low anterior resection syndrome. [PDF]
Wilson K +4 more
europepmc +1 more source
ABSTRACT Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome and is characterized by an accelerated adenoma‐carcinoma sequence, a relatively higher prevalence of flat and subtle CRC precursor lesions, and exceptionally high adenoma miss rates despite intensive colonoscopy surveillance.
Robert Hüneburg +3 more
wiley +1 more source
Case Report: Quantitative and qualitative evaluation for electroacupuncture combined with moxibustion in the treatment of recalcitrant low anterior resection syndrome. [PDF]
Hu C +5 more
europepmc +1 more source
ABSTRACT Colorectal cancer (CRC) remains a leading cause of cancer‐related morbidity and mortality worldwide yet is largely preventable through effective screening and surveillance. While most CRC cases are sporadic, a substantial proportion occur in individuals at increased risk due to hereditary cancer syndromes or family history who require tailored
Ophir Gilad +5 more
wiley +1 more source
Michał M. Nowakowski +9 more
doaj +1 more source
As third‐generation EGFR‐tyrosine kinase inhibitors, both aumolertinib and osimertinib demonstrate clinical efficacy for non‐small cell lung adenocarcinoma, especially in patients with brain metastases. Currently, head‐to‐head studies comparing these two agents in real‐world settings are scarce.
Jinxia Wang +9 more
wiley +1 more source
Die endoluminale Vakuumtherapie zur Behandlung der Anastomoseninsuffizienz nach Rektumresektion im Vergleich zur konventionellen endoskopischen Therapie [PDF]
Wiecken, Timm
core +1 more source

